Activity 2: Quality Management of Type 2 Diabetes: Approach to Medical Treatment

Program Overview

Selecting and optimizing therapy in patients with type 2 diabetes can be particularly challenging for clinicians. As the disease progresses, multiple therapies often are needed to maintain glycemic control and, ultimately, as beta-cell function declines, insulin therapy is required. By using the various classes of antihyperglycemic agents to individualize treatment and blood glucose monitoring to guide therapy, family physicians can help to improve glycemic control and clinical outcomes in patients with type 2 diabetes. As patients with type 2 diabetes are at high risk for macrovascular as well as microvascular complications, it is important to integrate CVD risk reduction strategies into the diabetes management plan.

In Quality Management of Type 2 Diabetes: Approach to Medical Treatment, the first video discussion of our educational series on type 2 diabetes, join Dr. John Russell, a practicing family physician, as he poses his burning clinical questions about diabetes management to Dr. Serena Cardillo, an endocrinologist at the Hospital of the University of Pennsylvania. Their discussion will focus on the subtleties of using antihyperglycemic medications, challenges and considerations when introducing insulin, use of blood glucose monitoring to guide treatment and the importance of CVD risk reduction.

Intended Audience

This continuing medical education program is intended for family practitioners and other healthcare professionals who manage type 2 diabetes.

Learning Objectives

After completing this activity, participants will be better able to:

• Select appropriate medical therapy, including insulin when appropriate, to achieve and maintain optimal glycemic control in patients with type 2 diabetes.
• Apply evidence-based treatment recommendations for management of type 2 diabetes.
• Use glucose monitoring to guide treatment and assist patients in achieving glycemic control.
• Develop a comprehensive plan of care for patients with type 2 diabetes, including CVD risk management.

Faculty

John Russell, MD
Associate Director of Family Medicine Residency
Abington Memorial Hospital
Clinical Associate Professor of Family and Community Medicine
Temple University School of Medicine

Serena Cardillo, MD
Assistant Professor of Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA

Planning Committee

Neil Skolnik, MD
Professor of Family and Community Medicine
Temple University School of Medicine
Family Medicine Residency Program
Abington Memorial Hospital
Abington, PA

Serena Cardillo, MD
Assistant Professor of Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA

Frances Love, MSN, RN, CDE, BC-ADM
Clinical Nurse Specialist/Diabetes Education Coordinator
PENN Rodebaugh Diabetes Center, Univ of Pennslyvania
Philadelphia, PA

John Russell, MD
Associate Director of Family Medicine Residency
Abington Memorial Hospital
Clinical Associate Professor of Family and Community Medicine
Temple University School of Medicine

CME Accreditation

This activity has been reviewed and is acceptable for up to 2 Prescribed credits by the American Academy of Family Physicians. Of these credits, 1 conforms to the AAFP criteria for evidence-based CME clinical content. CME credit has been increased to reflect 2 for 1 credit for only the EB CME portion. AAFP accreditation begins September 1, 2009. The term of approval is for two years from this date with the option of yearly renewal. When reporting AAFP credit, claim total Prescribed and Elective credit for this activity. It is not necessary to label credit as evidence-based CME for reporting purposes.

The EB CME credit awarded for this activity was based on a current clinical question that identifies gaps in learners’ knowledge, competency and/or performance in medical practice as identified in the current evidence available at the time this activity was approved. Since clinical research is ongoing and new evidence to supporting practice improvement is constant, the AAFP recommends that learners verify sources and review these as well as practice recommendations prior to implementation into practice.

The AAFP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Academy of Family Physicians designates this education activity for a maximum of 1.0 AMA PRA Category 1 credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Agenda

Introduction and Opening Remarks
Module 1: Selecting the Right Regimen for the Right Patient
Module 2: Criteria and Considerations to Initiate Insulin Therapy
Module 3: Glucose Monitoring
Module 4: Comprehensive Diabetes Care
Closing Remarks

Disclosures:

It is the policy of the AAFP that all CME planning committee/faculty/authors/editors/staff disclose relationships with commercial entities upon nomination/invitation of participation. Disclosure documents are reviewed for potential conflict of interests and, if identified, they are resolved prior to confirmation of participation. Only these participants who have no conflict of interest or who agree to an identified resolution process prior to their participation were involved in this CME activity.

The AAFP and MedEd Architects staffs have indicated that they have no relationships to disclose relating to the subject matter of the activity. Drs. Skolnik, Cardillo, Love, and Russell have returned a disclosure form indicating that she/he have no financial interest in or affiliation with any commercial supporter or providers of any commercial services discussed in this educational material.

Please note that faculty is required to disclose all relevant relationships prior to the beginning of the activity.